Literature DB >> 22214209

Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis.

Alfonso Maresca1, Andrea Scozzafava, Daniela Vullo, Claudiu T Supuran.   

Abstract

A series of halogenated sulfanilamides and halogenated benzolamide derivatives have been investigated as inhibitors of three β-carbonic anhydrases (CAs, EC 4.2.1.1) from the bacterial pathogen Mycobacterium tuberculosis, mtCA 1 (Rv1284), mtCA 2 (Rv3588c) and mtCA 3 (Rv3273). All three enzymes were inhibited with efficacies between the submicromolar to the micromolar one, depending on the substitution pattern at the sulfanilamide moiety/fragment of the molecule. Best inhibitors were the halogenated benzolamides (K(I)s in the range of 0.12-0.45 μM) whereas the halogenated sulfanilamides were slightly less inhibitory (K(I)s in the range of 0.41-4.74 μM). This class of β-CA inhibitors may have the potential for developing antimycobacterial agents with a diverse mechanism of action compared to the clinically used drugs for which many strains exhibit multi-drug/extensive multi-drug resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214209     DOI: 10.3109/14756366.2011.645539

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  10 in total

1.  Designing of phenol-based β-carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach.

Authors:  Shahzaib Ahamad; Md Imtaiyaz Hassan; Neeraja Dwivedi
Journal:  3 Biotech       Date:  2018-05-14       Impact factor: 2.406

Review 2.  Small Molecules That Sabotage Bacterial Virulence.

Authors:  Benjamin K Johnson; Robert B Abramovitch
Journal:  Trends Pharmacol Sci       Date:  2017-02-14       Impact factor: 14.819

3.  A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.

Authors:  Murat Bozdag; Melissa Pinard; Fabrizio Carta; Emanuela Masini; Andrea Scozzafava; Robert McKenna; Claudiu T Supuran
Journal:  J Med Chem       Date:  2014-11-10       Impact factor: 7.446

4.  Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.

Authors:  Martin Krátký; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Molecules       Date:  2017-03-28       Impact factor: 4.411

Review 5.  Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.

Authors:  Ashok Aspatwar; Jean-Yves Winum; Fabrizio Carta; Claudiu T Supuran; Milka Hammaren; Mataleena Parikka; Seppo Parkkila
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

6.  Ascaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis.

Authors:  Reza Zolfaghari Emameh; Marianne Kuuslahti; Daniela Vullo; Harlan R Barker; Claudiu T Supuran; Seppo Parkkila
Journal:  Parasit Vectors       Date:  2015-09-18       Impact factor: 3.876

7.  Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.

Authors:  P V Sri Ramya; Srinivas Angapelly; Andrea Angeli; Chander Singh Digwal; Mohammed Arifuddin; Bathini Nagendra Babu; Claudiu T Supuran; Ahmed Kamal
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

8.  Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates.

Authors:  Alessio Nocentini; Daniela Vullo; Sonia Del Prete; Sameh M Osman; Fatmah A S Alasmary; Zeid AlOthman; Clemente Capasso; Fabrizio Carta; Paola Gratteri; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

9.  Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics.

Authors:  Mujahid Abas; Hummera Rafique; Shazia Shamas; Sadia Roshan; Zaman Ashraf; Zafar Iqbal; Hussain Raza; Mubashir Hassan; Khurram Afzal; Albert A Rizvanov; Muhammad Hassham Hassan Bin Asad
Journal:  Biomed Res Int       Date:  2020-02-20       Impact factor: 3.411

Review 10.  Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs.

Authors:  Ashok Aspatwar; Visvaldas Kairys; Sangeetha Rala; Mataleena Parikka; Murat Bozdag; Fabrizio Carta; Claudiu T Supuran; Seppo Parkkila
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.